Viral Threats Research
Abstract
This effort designs and laboratory tests new vaccine candidates against hemorrhagic fever viruses, i.e. Dengue Virus, Hantaviruses Lassa fever Virus and Crimean-Congo hemorrhagic fever virus, and assesses other non-vaccine technologies to protect against hemorrhagic fever viruses. Efforts also include establishing and maintaining of clinical trial sites worldwide.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2018
- Source ID
- f5505c266f2968b96f1fcee52ef113c7
Related Documents
- Root: Medical Technology